Cargando…

Basic and clinical immunology – 3022. Inhibitory action of fexofenadine hydrochloride on mast cell activation in vitro

Detalles Bibliográficos
Autores principales:	Suzuki, Miyuki, Furuta, Atsuko, Asano, Kazuhito, Suzaki, Harumi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	World Allergy Organization 2013
Materias:	Meeting Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3643522/ http://dx.doi.org/10.1186/1939-4551-6-S1-P198

Ejemplares similares

Basic and clinical immunology – 3021. Inhibitory action of levocetirzine hydrochloride on eosinophil actication in vitro
por: Furuta, Atsuko, et al.
Publicado: (2013)

Basic and clinical immunology – 3023. Influence of fexofenadine hydrochloride on uteroglobin production from nasal epithelial cells in vitro and in vivo
por: Kanai, Kenichi, et al.
Publicado: (2013)

Basic and clinical immunology – 3025. Suppression of eosinphil activation by levocetirizine hydrochloride in vivo
por: Kawaguchi, Kenichiro, et al.
Publicado: (2013)

Influence of Epinastine Hydrochloride, an H(1)-Receptor Antagonist, on the Function of Mite Allergen-Pulsed Murine Bone Marrow-Derived Dendritic Cells In Vitro and In Vivo
por: Oshima, Ken-Zaburo, et al.
Publicado: (2009)

Inhibitory action of a macrolide antibiotic, roxithromycin, on co-stimulatory molecule expressions in vitro and in vivo.
por: Suzuki, Mayumi, et al.
Publicado: (2002)

Inhibition of Angiogenic Factor Production from Murine Mast Cells by an Antiallergic Agent (Epinastine Hydrochloride) In Vitro
por: Asano, K., et al.
Publicado: (2008)

Fexofenadine hydrochloride in the treatment of allergic disease: a review
por: Axelrod, David, et al.
Publicado: (2008)

Effect of fexofenadine hydrochloride on allergic rhinitis aggravated by air pollutants
por: Ellis, Anne K., et al.
Publicado: (2021)

Stability-indicating HPLC Method for Simultaneous Determination of Montelukast and Fexofenadine Hydrochloride
por: Pankhaniya, Mona, et al.
Publicado: (2013)

Insights into urticaria in pediatric and adult populations and its management with fexofenadine hydrochloride
por: Ansotegui, Ignacio J., et al.
Publicado: (2022)

Cubosomes for Enhancing Intestinal Absorption of Fexofenadine Hydrochloride: In situ and in vivo Investigation
por: Sultan, Amal A, et al.
Publicado: (2022)

Taste Masked Orodispersible Formulation of Fexofenadine Hydrochloride Using Ion Exchange Resins
por: Suares, Divya, et al.
Publicado: (2015)

Correction to: Insights into urticaria in pediatric and adult populations and its management with fexofenadine hydrochloride
por: Ansotegui, Ignacio J., et al.
Publicado: (2022)

Solid Form and Phase Transformation Properties of Fexofenadine Hydrochloride during Wet Granulation Process
por: Li, Suye, et al.
Publicado: (2021)

Double blind randomized crossover trial of PF-03654764+fexofenadine in the environmental exposure unit (EEU)
por: North, Michelle L, et al.
Publicado: (2014)

Improved Dissolution Rate and Intestinal Absorption of Fexofenadine Hydrochloride by the Preparation of Solid Dispersions: In Vitro and In Situ Evaluation
por: Eedara, Basanth Babu, et al.
Publicado: (2021)

Application of green first derivative synchronous spectrofluorometric method for quantitative analysis of fexofenadine hydrochloride and pseudoephedrine hydrochloride in pharmaceutical preparation and spiked human plasma
por: Ramzy, Sherif, et al.
Publicado: (2022)

Fexofenadine-Induced Urticaria
por: Lee, Sang Woo, et al.
Publicado: (2011)

Development of validated stability-indicating chromatographic method for the determination of fexofenadine hydrochloride and its related impurities in pharmaceutical tablets
por: Maher, Hadir M, et al.
Publicado: (2011)

Inhibitory Action of Quercetin on Eosinophil Activation In Vitro
por: Sakai-Kashiwabara, Misako, et al.
Publicado: (2013)

Suppression of IL-8 production from airway cells by tiotropium bromide in vitro
por: Suzaki, Isao, et al.
Publicado: (2011)

Influence of a macrolide antibiotic, roxithromycin, on mast cell growth and activation in vitro.
por: Shimane, T, et al.
Publicado: (2001)

Suppression of matrix metalloproteinase-9 production from neutrophils by a macrolide antibiotic, roxithromycin, in vitro.
por: Kanai, Ken-Ichi, et al.
Publicado: (2004)

Suppressive Activity of Vitamin D3 on Matrix Metalloproteinase Production From Cholesteatoma Keratinocytes In Vitro
por: Kobayashi, Hitome, et al.
Publicado: (2005)

Suppression of Osteopontin Functions by Levocetirizine, a Histamine H(1) Receptor Antagonist, In Vitro
por: Komatsuzaki, Toshimitsu, et al.
Publicado: (2013)

Suppression of Matrix Metalloproteinase Production in Nasal Fibroblasts by Tranilast, an Antiallergic Agent, In Vitro
por: Shimizu, Toshiyuki, et al.
Publicado: (2005)

New pencil graphite electrodes for potentiometric determination of fexofenadine hydrochloride and montelukast sodium in their pure, synthetic mixtures, and combined dosage form
por: Nashed, Dania, et al.
Publicado: (2020)

Immunology, Immunotherapy, and Translating Basic Science into the Clinic for Bladder Cancer
por: Ingersoll, Molly A., et al.
Publicado: (2018)

Quercetin-Induced Enhancement of Nasal Epithelial Cells’ Ability to Produce Clara Cell 10-kD Protein In Vitro and In Vivo
por: Otaki, Amane, et al.
Publicado: (2023)

Tiotropium bromide inhibits TGF-β-induced MMP production from lung fibroblasts by interfering with Smad and MAPK pathways in vitro
por: Asano, Kazuhito, et al.
Publicado: (2010)

Suppression of nitric oxide production from nasal fibroblasts by metabolized clarithromycin in vitro
por: Furuya, Ayako, et al.
Publicado: (2010)

Fexofenadine Suppresses Delayed-Type Hypersensitivity in the Murine Model of Palladium Allergy
por: Matsubara, Ryota, et al.
Publicado: (2017)

Study of the Complexation Behaviour of Fexofenadine with β-Cyclodextrin
por: Sapkal, Nidhi P., et al.
Publicado: (2010)

Fexofenadine in higher doses in chronic spontaneous urticaria
por: Godse, Kiran V., et al.
Publicado: (2010)

Acute Generalized Exanthematous Pustulosis Induced by Fexofenadine
por: Gupta, Tanvi, et al.
Publicado: (2016)

Restless legs syndrome induced by fexofenadine/pseudoephedrine
por: Nishioka, Hiroaki, et al.
Publicado: (2020)

Basic and clinical immunology – 3015. Nonspecific defense factors in premature infants with pneumonia
por: Alimova, Kamola, et al.
Publicado: (2013)

Basic and clinical immunology – 3016. Successful desensitization to oxaliplatin for metastic colorectal carcinoma
por: Buddiga, Praveen, et al.
Publicado: (2013)

QTc interval prolongation by fexofenadine in healthy human volunteers and its correlation with plasma levels of fexofenadine: A demonstration of anticlockwise hysteresis
por: Vyas, Falgun I., et al.
Publicado: (2010)

Basic and clinical immunology – 3034. Peculiarities of parameters immune system in juvenile rheumatoid arthritis
por: Musakhodjaeva, Diloram Abdullaevna, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_l17pflo203sgfn7ov9b5kbubfr